Goldman Sachs PerkinElmer Reaches Deal for $1.5B Credit Facility The agreement is for a new credit facility, which replaces one from 2019 that provided for a $1 billion unsecured revolving credit facility. PerkinElmer Enters $500M Credit Facility The proceeds will be used to pay, in part, PerkinElmer's $5.25B acquisition of BioLegend, announced last month. Singular Genomics Ups IPO Target to $187M The San Diego-based DNA sequencing startup plans to offer 8.5 million shares at an IPO price between $20 and $22 per share, for a $1.5 billion valuation. Sequencing Startup Singular Genomics Files for $100M IPO The San Diego-based company, led by a raft of Illumina veterans, is planning to build a new sequencing platform to address genomic and multiomic analysis. Twist Bioscience Proposes $250M Public Offering Included in the offering — Twist Bioscience's third this year — are 75,000 shares of common stock offered by certain selling shareholders. Jul 29, 2020 Sema4 Raises $121M in Series C Financing Round Jul 16, 2020 Adaptive Biotechnologies to Raise $240M in Public Stock Offering Jan 24, 2020 Adaptive Biotechnologies Prices Public Offering of Stock Jan 21, 2020 Adaptive Biotechnologies Announces Preliminary FY19 Revenue Increase, $257M Stock Offering Sep 25, 2019 Thermo Fisher Scientific Prices $5.7B Senior Notes Offering Aug 20, 2019 10x Genomics Files for $100M IPO Feb 27, 2019 Danaher Prices $2.76B Offering of Common, Preferred Stock Dec 8, 2015 Goldman Sachs Upgrades Myriad, Agilent, and Thermo Fisher; Downgrades PerkinElmer, Danaher Dec 18, 2014 Goldman Sachs Downgrades Qiagen, Bruker Sep 2, 2014 Goldman Sachs, Leerink Initiate Coverage of T2 Biosystems Jun 23, 2014 Goldman Sachs Reinstates Neutral Rating for Agilent Jun 25, 2013 Goldman Sachs Upgrades Waters; Downgrades Agilent, Genomic Health Apr 23, 2013 Quest Enters into Agreement to Buy Back $450M of Stock Apr 11, 2013 Goldman Sachs Upgrades Quest, LabCorp, Downgrades Sigma-Aldrich Mar 28, 2013 T2 Biosystems Raises $40M Jan 16, 2013 Goldman Sachs Survey Finds Spending on Life Science Tools Remains Challenged by Funding, Fiscal Concerns Dec 6, 2012 Goldman Sachs Resumes Coverage of Danaher with Neutral Rating Nov 19, 2012 Goldman Sachs Upgrades Agilent, Bruker; Lowers Cepheid, LabCorp Oct 11, 2012 Goldman Sachs Initiates Coverage of Genomic Health with Neutral Rating Oct 9, 2012 Analysts, Investors 'Troubled' as Affymetrix's Preliminary Q3 Revenues Miss Estimates Premium Load More Breaking News In Ongoing False Advertising Suit, Judge Allows Natera Counterclaims Against Guardant Health Centogene Strikes Rare Disease Target Discovery Deal With Insilico Medicine Dilated Cardiomyopathy Gene Mutations Point to Possible Therapeutic Strategy Ginkgo Bioworks Acquires Massachusetts COVID-19 Testing Firm Mainz Biomed Taps DCN Dx to Aid European Study of Enhanced ColoAlert Assay Parse Biosciences Partners With Research Instruments for Southeast Asia Distribution The Scan Transplant Tests Edited Pig Kidneys The Associated Press reports a University of Alabama-Birmingham team transplanted genetically modified pig kidneys into a brain-dead human patient. UK Changes Some Gene-Edited Crop Rules A new law may enable gene-edited crops to be sold in the UK within about five years, New Scientist says. Pill Works Against Omicron in Lab Pfizer's antiviral pill to treat SARS-CoV-2 appears to work against the Omicron variant, the Wall Street Journal reports. Nature Papers Find Genetic Risk Factor for Smell, Taste Loss in COVID-19; Analyze TB Granulomas In Nature this week: genome-wide association study find locus linked to the risk COVID-19 patients losing their sense of taste or smell, and more.